These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22820918)

  • 1. Are blood stream infections associated with an increased risk of hemorrhagic stroke in patients with a left ventricular assist device?
    Aggarwal A; Gupta A; Kumar S; Baumblatt JA; Pauwaa S; Gallagher C; Treitman A; Pappas P; Tatooles A; Bhat G
    ASAIO J; 2012; 58(5):509-13. PubMed ID: 22820918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent blood stream infection in patients supported with a continuous-flow left ventricular assist device is associated with an increased risk of cerebrovascular accidents.
    Trachtenberg BH; Cordero-Reyes AM; Aldeiri M; Alvarez P; Bhimaraj A; Ashrith G; Elias B; Suarez EE; Bruckner B; Loebe M; Harris RL; Zhang JY; Torre-Amione G; Estep JD
    J Card Fail; 2015 Feb; 21(2):119-25. PubMed ID: 25463739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood stream infection is associated with cerebrovascular accident in patients with left ventricular assist device: a systematic review and meta-analysis.
    Kanjanahattakij N; Horn B; Abdulhadi B; Wongjarupong N; Mezue K; Rattanawong P
    J Artif Organs; 2018 Sep; 21(3):271-277. PubMed ID: 29546615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
    Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
    J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of complications following left ventricular assist device placement.
    Yuan N; Arnaoutakis GJ; George TJ; Allen JG; Ju DG; Schaffer JM; Russell SD; Shah AS; Conte JV
    J Card Surg; 2012 Sep; 27(5):630-8. PubMed ID: 22978843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurologic events with a totally implantable left ventricular assist device: European LionHeart Clinical Utility Baseline Study (CUBS).
    Pae WE; Connell JM; Boehmer JP; Korfer R; El-Banayosy A; Hetzer R; Vigano M; Pavie A;
    J Heart Lung Transplant; 2007 Jan; 26(1):1-8. PubMed ID: 17234510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
    Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
    Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD
    J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices.
    Argenziano M; Catanese KA; Moazami N; Gardocki MT; Weinberg AD; Clavenna MW; Rose EA; Scully BE; Levin HR; Oz MC
    J Heart Lung Transplant; 1997 Aug; 16(8):822-31. PubMed ID: 9286774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure.
    Dang NC; Topkara VK; Mercando M; Kay J; Kruger KH; Aboodi MS; Oz MC; Naka Y
    J Heart Lung Transplant; 2006 Jan; 25(1):1-6. PubMed ID: 16399523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk analysis of bloodstream infection during long-term left ventricular assist device support.
    Toda K; Yonemoto Y; Fujita T; Shimahara Y; Sato S; Nakatani T; Kobayashi J
    Ann Thorac Surg; 2012 Nov; 94(5):1387-93. PubMed ID: 22571882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients.
    Ochiai Y; McCarthy PM; Smedira NG; Banbury MK; Navia JL; Feng J; Hsu AP; Yeager ML; Buda T; Hoercher KJ; Howard MW; Takagaki M; Doi K; Fukamachi K
    Circulation; 2002 Sep; 106(12 Suppl 1):I198-202. PubMed ID: 12354733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and management of gastrointestinal bleeding with continuous flow assist devices.
    Aggarwal A; Pant R; Kumar S; Sharma P; Gallagher C; Tatooles AJ; Pappas PS; Bhat G
    Ann Thorac Surg; 2012 May; 93(5):1534-40. PubMed ID: 22541185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
    Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
    J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal bleeding with the HeartMate II left ventricular assist device.
    Morgan JA; Paone G; Nemeh HW; Henry SE; Patel R; Vavra J; Williams CT; Lanfear DE; Tita C; Brewer RJ
    J Heart Lung Transplant; 2012 Jul; 31(7):715-8. PubMed ID: 22425231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Cerebral Microbleeds in Patients With Continuous-Flow Left Ventricular Assist Devices.
    Yoshioka D; Okazaki S; Toda K; Murase S; Saito S; Domae K; Miyagawa S; Yoshikawa Y; Daimon T; Sakaguchi M; Sawa Y
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28893764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.